Antibody Solutions
Antibody Solutions is a Santa Clara-based fee-for-service contract research organization specializing in monoclonal antibody discovery via its proprietary Cellestive multi-pathway B-cell platform, serving 700+ biopharma clients including all top 10 global pharmaceutical companies since 1995.
- Company typePrivate
- Founded1995
- HeadquartersSanta Clara, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Antibody Solutions does
Antibody Solutions is a privately held, fee-for-service contract research organization headquartered in Santa Clara, California, founded in 1995 and operating for 30 years. The company offers monoclonal antibody discovery services to biopharma customers through its proprietary Cellestive Discovery Platform, which executes multi-pathway B-cell screening across plasma, activated, and memory B-cell populations. Its client base exceeds 700 accounts and includes all of the top 10 global pharmaceutical companies alongside a long-tail of mid-market and emerging biopharma sponsors.
The business model is pay-as-you-go fee-for-service work in which clients retain full intellectual property rights to the antibodies and clones generated. Antibody Solutions does not take equity, milestone, or royalty positions in client programs, and the company is family-owned with no disclosed external institutional investors. Service delivery is anchored at its Santa Clara laboratory at 3033 Scott Boulevard, with project management functions supporting each engagement from kickoff through clone delivery.
The technology stack is centered on the Cellestive platform, which combines traditional hybridoma workflows with capabilities sourced through partnerships — including OmniAb (since 2012), Single Cell Technology (2017), and mAbsolve (2023) — to extend into single-cell and anti-idiotype workflows. In 2024 the company added a partnership with Leveragen and secured a $1.2 million grant from the Bill & Melinda Gates Foundation to develop malaria diagnostic antibodies, signaling selective entry into global-health reagent development alongside its commercial discovery services.
Antibody Solutions firmographics
Firmographics- Name
- Antibody Solutions
- Legal name
- Antibody Solutions
- Website
- https://antibody.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Antibody Solutions is a Santa Clara-based fee-for-service contract research organization specializing in monoclonal antibody discovery via its proprietary Cellestive multi-pathway B-cell platform, serving 700+ biopharma clients including all top 10 global pharmaceutical companies since 1995.
- Ownership category
- akta.pro rank
Antibody Solutions industry classification
Industry- Product category
- Contract Research Organization (Antibody Discovery Services)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Monoclonal Antibody Therapeutics (mAbs) (HLAAAAAA), Antibody-Drug Conjugates (ADCs) & Antibody Conjugates (HLAAAAAE)
Keywords
Where Antibody Solutions is headquartered
LocationHeadquarters
- HQ city
- Santa Clara
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Antibody Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Fee-for-Service Antibody Discovery Services: Antibody Solutions provides custom antibody discovery and development services on a fee-for-service, pay-as-you-go basis. Clients pay for individual services or projects as needed, with pricing based on the scope and complexity of each engagement. The model allows clients to retain their IP rights.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Fee-for-service custom services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Antibody Solutions product offering
Product offeringCore offering
Antibody Solutions is a contract research organization that designs and executes custom antibody discovery and development programs for biopharmaceutical companies. Its core offering is the Cellestive Discovery Platform, which interrogates plasma, activated, and memory B-cells across multiple transgenic animal platforms to generate fit-for-purpose monoclonal, polyclonal, bispecific, ADC, and single-domain antibodies for therapeutic and diagnostic use. Services are delivered on a fee-for-service, pay-as-you-go basis with clients retaining intellectual property rights.
Product overview
Antibody Solutions offers a comprehensive antibody discovery platform centered around the Cellestive Discovery Platform, which leverages multiple B-cell pathways (plasma, activated, and memory B-cells) to generate diverse therapeutic antibody candidates. The platform is supported by an integrated suite of services including antigen development, hybridoma and single B-cell screening technologies, transgenic animal platforms (OmniAb, H2L2, Singularity Sapiens Mouse), antibody manufacturing, molecular modeling, bioconjugation, and sequencing services. The company operates on a fee-for-service, pay-as-you-go model serving biopharmaceutical clients worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Cellestive: Antibody discovery platform that interrogates multiple B-cell populations (activated, memory, and plasma B-cells) for therapeutic antibody discovery
Products and services
- Cellestive Discovery Platform Proprietary antibody discovery platform that interrogates plasma, activated, and memory B-cells to generate diverse antibody repertoires for therapeutic and diagnostic applications; integrated with hybridoma screening, single B-cell analysis, FACS-based screening, and recombinant antibody expression capabilities.
- Therapeutic Antibody Discovery Custom discovery services using transgenic animals and alternative antibody modalities for developing therapeutic antibody candidates for biopharmaceutical clients.
- Critical Reagent Antibody Discovery Antibody discovery services focused on generating highly specific and reproducible critical reagents for diagnostic and research applications, including PK/PD, ADA, IHC, and Western blot assays.
- Monoclonal Antibody Discovery Monoclonal antibody generation services using hybridoma and B-cell screening technologies for therapeutic and diagnostic applications.
- Polyclonal Antibody Discovery Polyclonal antibody discovery services for research and diagnostic applications.
- Antibody Manufacturing Scale-up antibody manufacturing services for preclinical and clinical applications.
- Antigen Development Antigen design and development services supporting antibody discovery programs.
- Bioconjugation Antibody bioconjugation services for developing antibody-drug conjugates (ADCs) and other conjugated therapeutics.
- Antibody Catalog Online catalog of pre-existing antibodies available for purchase for research and diagnostic applications.
- Singularity Sapiens Mouse Platform Services CRO antibody discovery services using Leveragen's next-generation fully human single-domain antibody platform that generates heavy chain antibodies from the complete human VH repertoire.
Quantifiable outcome
- 96% of clients return with new assignments
- +1 more outcomes
Companies that use Antibody Solutions
Customer profileSegments1 record
Ideal customer profiles2 records
Antibody Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Antibody Solutions partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Leveragen, Inc.coreAntibody Solutions became an approved contract research organization (CRO) for Leveragen's Singularity Sapiens Mouse platform. This next-generation fully human single-domain antibody platform exclusively generates heavy chain antibodies through a targeted approach ensuring faithful expression of human immunoglobulin genes and eliminating interfering conventional antibodies. The partnership allows Antibody Solutions to pursue antibody discovery initiatives using Leveragen mice for clients who have licensed the proprietary platform.
- mAbsolve Ltd.coreAntibody Solutions licensed mAbsolve's STR Fc silencing technology, providing clients with easy license-free access to this best-in-class Fc silencing platform for antibody research and development. The STR technology is described as the only truly silent Fc mutation platform, improving safety and efficacy of therapeutic antibodies and Fc fusion proteins by completely silencing unwanted binding to Fc gamma receptors.
- Single Cell Technology, Inc. (SCT)coreAntibody Solutions partnered with Single Cell Technology to integrate SCT's AbTHENEUM single B-cell analysis technology with Antibody Solutions' comprehensive antibody discovery platform. This partnership enables phenotypic screening of secreted antibodies from individual B-cells and correct pairing of cognate VH and VL sequences via NGS, allowing more comprehensive interrogation of immunized animal repertoires.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Antibody Solutions competitors and assessment
Company assessmentDirect peers
- GenScript ProBio: Global CRO/CDMO offering antibody discovery, engineering, and manufacturing services. Directly comparable across therapeutic antibody discovery, hybridoma, and transgenic animal workflows, with similar biopharma buyer personas.
- AbCellera Biologics: Vancouver-based antibody discovery CRO with a proprietary single-cell screening platform. Most direct comparability: same fee-for-service discovery model serving top global pharmas, plus a therapeutic pipeline - making it the closest publicly-traded reference point for Antibody Solutions' service business.
- Sino Biological: Producer of recombinant antibody reagents and CRO services for therapeutic and diagnostic antibody discovery. Comparable hybrid business model combining catalog reagents with custom services.
- Absolute Antibody: Antibody CRO focused on antibody engineering, sequencing, and recombinant expression. Comparable mid-size fee-for-service offering for biopharma clients needing fit-for-purpose reagents and engineered formats.
- ImmunoPrecise Antibodies: Specialized CRO providing custom antibody discovery and characterization using multiple platforms including B-cell screening and transgenic animals. Closely matched size and service mix to Antibody Solutions.
- Curia (formerly LakePharma): Contract development and manufacturing organization with antibody discovery and bioconjugation services. Comparable custom antibody and ADC-adjacent service offerings for biopharma clients.
Broad incumbents
- Lonza Biologics: Global CDMO offering end-to-end biologics services including antibody discovery and manufacturing. Larger incumbent that competes for the same biopharma wallets, particularly on integrated discovery-to-manufacturing programs.
- Bio-Techne: Established life sciences tools and reagents company with antibody-related products and services. Larger portfolio player with overlap on critical reagent antibodies and assay development, but with a much broader catalog footprint.
- WuXi Biologics: Global CRDMO with antibody discovery, development, and manufacturing services. Competes for the same top-pharma discovery programs but at much larger scale, often as the integrated-services alternative to a specialized CRO like Antibody Solutions.
- Charles River Laboratories: Large CRO with comprehensive discovery and safety assessment services including antibody and biologics capabilities. Relevant as a broad incumbent buyer of outsourced discovery work from biopharma clients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Antibody Solutions social profiles
Digital presenceAntibody Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Antibody Solutions leadership team
Management profileNumber of profiles
Profiles5 records
Antibody Solutions funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Antibody Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Antibody Solutions
What does Antibody Solutions do?
Antibody Solutions is a contract research organization that designs and executes custom antibody discovery and development programs for biopharmaceutical companies. Its core offering is the Cellestive Discovery Platform, which interrogates plasma, activated, and memory B-cells across multiple transgenic animal platforms to generate fit-for-purpose monoclonal, polyclonal, bispecific, ADC, and single-domain antibodies for therapeutic and diagnostic use. Services are delivered on a fee-for-service, pay-as-you-go basis with clients retaining intellectual property rights.
Is Antibody Solutions a public or private company?
Antibody Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Antibody Solutions founded?
Antibody Solutions was founded in 1995. It employs 11 to 50 people.
Where is Antibody Solutions based?
Antibody Solutions is headquartered in Santa Clara, United States, in the North America region.
How does Antibody Solutions make money?
One revenue line is on record: fee-for-Service Antibody Discovery Services.
Who are Antibody Solutions's main competitors?
Direct peers on record are GenScript ProBio, AbCellera Biologics, Sino Biological, Absolute Antibody, ImmunoPrecise Antibodies and Curia (formerly LakePharma). Broad incumbents are Lonza Biologics, Bio-Techne, WuXi Biologics and Charles River Laboratories.
Does Antibody Solutions have an API?
No public API is recorded for Antibody Solutions.
What industry is Antibody Solutions in?
Antibody Solutions's product category is Contract Research Organization (Antibody Discovery Services). Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 541714 and its SIC code is 8731.